GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XSWX:NWRN) » Definitions » Deferred Tax

Newron Pharmaceuticals SpA (XSWX:NWRN) Deferred Tax : CHF4.95 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Newron Pharmaceuticals SpA Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Newron Pharmaceuticals SpA's change in deferred tax for the six months ended in Dec. 2023 was CHF1.83 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2023 was CHF4.95 Mil.

Newron Pharmaceuticals SpA Deferred Tax Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Deferred Tax Chart

Newron Pharmaceuticals SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.55 -1.10 3.63 4.89 4.84

Newron Pharmaceuticals SpA Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.34 2.86 2.14 3.12 1.83

Newron Pharmaceuticals SpA Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF4.95 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Newron Pharmaceuticals SpA Deferred Tax Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Newron Pharmaceuticals SpA (XSWX:NWRN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XSWX:NWRN) » Definitions » Deferred Tax
Comparable Companies
XSWX:MOLN XSWX:SANN XSWX:XLS XSWX:RLF XSWX:ADXN XSWX:EVE XSWX:KNRS XSWX:SPEX XSWX:BSLN XSWX:IDIA OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 MRNA XKRX:068270 XBRU:ARGX XBRU:UCB BNTX
Traded in Other Exchanges
NWPHF:USA NP5:Germany
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Website
https://www.newron.com
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Executives
Patrick Langlois Supervisory Board

Newron Pharmaceuticals SpA (XSWX:NWRN) Headlines

No Headlines